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Declaration 
The material contained herein is original work and is not being submitted for another 
degree or to another institution. This work has not been published prior to registration 
for the MMed (Neurosurgery) degree. 
Abbreviations and Glossary of Terms 
CBF: Cerebral Blood Flow 
CCHU: Cure Children’s Hospital for Uganda 
CLD: Continuous Lumbar Drainage 
CNS: Central Nervous System 
CSF: Cerebrospinal Fluid  
CT: Computed Tomography 
DTPA: Diethylenetriamine Pentaacetic Acid 
EVD: External Ventricular Drain 
ETV: Endoscopic Third Ventriculostomy 
ETVSS: Endoscopic Third Ventriculostomy Success Score 
Hg: Mercury 
ICP: Intracranial Pressure 
ICU: Intensive Care Unit 
LP: Lumbar Puncture 
MCA: Middle Cerebral Artery 
mFV: Mean Flow Velocity 
MMC: Myelomeningocele 
MRI: Magnetic Resonance Image 
NPV: Negative Predictive Value 
PI: Pulsatility Index 
PPV: Positive Predictive Value 
ROC: Receiver Operator Curve 
SAS: Sub-arachnoid Space 
VPS: Ventriculoperitoneal Shunt 
VRI: Ventriculostomy Related Infection 
Area Under Receiver Operator Curve (AUROC) - The performance of a diagnostic 
variable can be quantified by calculating the area under the ROC curve (AUROC). 
The ideal test would have an AUROC of 1, whereas a random guess would have an 
AUROC of 0.5 6 
Elastance is the inversion of compliance, with the latter being the buffering capacity 
of the cerebrospinal compartment with increase in CSF volume.61 
Fisher’s exact test is a statistical significance test that is used in the analysis of 2x2 
tables where there are small sample sizes. It is used to examine the significance of 
association between two types of categorical data.62 
Hosmer–Lemeshow test is a commonly used test for assessing the goodness of fit of a 
model and allows for any number of explanatory variables.7  
Part A: Study Protocol 
Application for Approval: Research Protocol 
Principle Investigator: David Roytowski 
Supervisor: Prof. P Semple (Primary), Dr. L Padayachy (Secondary) 
Statistician: Mr. H Carrara  
Study Title:  
Intracranial Pressure Monitoring as an Early Predictor of Third Ventriculostomy 
Outcome 
Background: 
Hydrocephalus is a common neurosurgical condition that results from the 
accumulation of cerebrospinal fluid (CSF) within the ventricular system of the brain, 
due to disruption of the balance between CSF production and absorption. 
Hydrocephalus has been described as communicating (a production/absorption 
imbalance) or non-communicating (an obstruction within the CSF pathways). The 
mainstay of treatment for non-communicating hydrocephalus has been the creation of 
an artificial outflow pathway – the ventriculo-peritoneal shunt (VPS). 
While shunts have possibly been the most instrumental neurosurgical intervention in 
saving patients lives, they are fraught with problems and complications. 
An elegant alternative to the VPS is the endoscopic third ventriculostomy (ETV) – a 
‘key-hole’ neurosurgical procedure that creates an alternate CSF passage and 
reabsorption pathway, without the introduction of foreign body materials to the 
patient, thus, eliminating many of the complications associated with shunting. 
ETVs are generally not indicated for patients with communicating hydrocephalus. In 
the event of ETV failure, early recognition is necessary to prevent the potentially fatal 
consequences of raised intracranial pressure. 
Study Objective: 
This study aims to determine i) if early intracranial pressure monitoring (via a 
transduced external ventricular drain) can predict ETV outcome, ii) the value of 
intraoperative assessment in predicting ETV outcome, iii) usefulness of CSF analysis 
to predict ETV success and iv) the complication rate (including sepsis) the study 
population. 
Methodology  
The data was collected from folders and radiological studies (CT/MRI Scans) of 
patients admitted to the Neurosurgical ICU/High Care following ETV intervention 
from 2006 until 2011. 
The ICU data and subsequent follow up data from patient notes will be reviewed to 
determine the success or failure of the ETV. 
Patient inclusion criteria for ETV were those that demonstrated a non-
communicating/ tri-ventricular pattern of hydrocephalus or had evidence of VPS 
dysfunction and a radiographic picture that suggested the condition would be 
amenable to ETV.  
Standard Groote Schuur Hospital pre-surgical informed consent was attained in all 
cases.  
Patients would be ineligible for ETV if ventricular anatomy was distorted or there was 
evidence of intercurrent bacterial infection. 
Patients that underwent an ETV were admitted to the D13 ICU/High Care. 
Intracranial pressure (ICP) was monitored via an external ventricular drain (EVD), 
which was transduced for approximately 72 hours. Raised ICP (>25 mmHg) for a 
sustained period – was managed by CSF release via the EVD or by lumbar puncture. 
Repeated episodes of raised ICP despite CSF release would result in the patient 
receiving a VPS.  
Patient care followed best practice guidelines and all patients were treated on the 






Variable Type Variable Type 
No Numerical Repeat ETV? Binary 
Patient Alpha-numerical Evidence of EVD related Sepsis Binary 
GSH NO Numerical Complications Alpha-numerical 
Age Numerical ETV Fn at D/C Binary 
Gender Binary ETV Fn at F/U Binary 
Pathology Alpha-numerical ETV Fn at 6/12 F/U Binary 
Aetiology Categorised Post Op Scan ETV FN? Binary 
Max ICP Numerical CSF App Categorised 
Mean ICP Numerical Poly Numerical 
CSF Release Categorised Lymp Numerical 
Release Type Categorised RBC Numerical 
Monitoring Duration Categorised Bact Binary 
D1 ICP Numerical Culture Binary 
D2 ICP Numerical Additional comments Alpha-numerical 
D3 ICP Numerical ETV Date Date 
Intraop Findings Categorised 
Questions to be answered: 
Primary 
• Predictive quality of Monitoring? (i.e., does a monitoring outcome that is
positive equate to F/U and 6mo F/U ETV function?)
• Predictive quality of intraoperative assessment on ETV function at F/U and
6mo F/U
• Predictive quality of CSF picture on ETV function at F/U and 6mo F/U
Secondary 
• What is the rate of EVD related sepsis?
• Is there a Age, Gender, Aetiology, CSF release, Previous ETV correlation to
successful ETV at F/U and 6mo F/U
Part B: Literature Review 
Objectives of Literature Review 
A comprehensive literature review was performed to ascertain the current body of 
knowledge regarding the treatment of hydrocephalus, in particular by performing an 
endoscopic third ventriculostomy (ETV). The key focus of the literature review was 
to examine the means and modalities presently employed to predict success of the 
ETV procedure. The primary search engines employed were pubmed, medline and 
google scholar. The searches were not time bounded and included published article 
upto and including May 2011.  
Hydrocephalus 
Hydrocephalus is a disease that has been described since the times of Hippocrates, 
with its name originating from the Greek meaning “water” “head”. Since the early 
1900s, hydrocephalus has been described as either, “communicating” or “non-
communicating” (or “obstructive”). This is supported by the physiological theory that 
cerebrospinal fluid (CSF) is generated by the choroid plexus, has uninterrupted 
passage in the subarachnoid space (SAS) and is reabsorbed by the arachnoid 
granulations. Dandy outlined this physiology in his experiments on animals with 
injection of dye into the ventricular system that was later recovered in a spinal tap.51 
This theory has subsequently been questioned since recent evidence exists that 
indicate that the major CSF absorption occurs in the capillaries of the central nervous 
systems (CNS) and not the pacchionian granulations.29  
The contemporary definition of Hydrocephalus has taken into consideration the 
ventricular system size; Rekate suggested in 2008 that ‘hydrocephalus is an active 
distention of the ventricular system of the brain resulting from inadequate passage of 
cerebrospinal fluid from its point of production within the cerebral ventricles to its 
point of absorption into the systemic circulation.”52 Importantly, the definition does 
not make mention of the intracranial pressure, although an elevated intracranial 
pressure (ICP) often exists.  
The classification of hydrocephalus has been as complicated as reaching a consensus 
on its definition. A classification should be able to identify the pathology as well as be 
useful in delineating management. Currently a view is held that apart from 
overproduction of CSF (as in a Choroid plexus tumour) all forms of Hydrocephalus 
can be considered “obstructive”, at some point in the CSF passage.52  
Ventriculomegaly results when the normal CSF absorptive mechanisms are 
overwhelmed, with a concomitant increase in intracranial pressure. Three main 
mechanisms have been described for the disequilibrium resulting in hydrocephalus; 
increased CSF production, increased outflow resistance, and increased dural sinus 
pressure.57 An alternative theory is that increased pulsatility of the brain during 
systole, due to disruption of Monroe-Kelly homeostasis, causes an increased 
transmantle pressure gradient and ventriculomegaly.29 
The recent classification proposed by Rekate, seeks to highlight the site of 
obstruction, likely pathology and indicated management. 52 




None Choroid plexus papilloma Removal 
Foramen of 
Monro 
Tumour, congenital anomaly, post-
shunt ventricular asymmetry 
Tumour removal, septum 
pellucidotomy, ventricle shunt 
Aqueduct of 
Sylvius 
Congenital lesion, tumour secondary to 
extraventricular obstruction 
ETV, ventricular shunt 
Outlets of fourth 
ventricle 
Chronic meningitis, Chiari II 
malformation 
ETV, ventricular shunt 
Basal cisterns Meningitis, post subarachnoid 
haemorrhage 




Haemorrhage or infection in infancy Ventricle or thecal shunt 
Venous outflow Skull base anomalies, congenital heart 
disease 
Ventricle or thecal shunt, treatment of 
vascular anomaly (if possible) 
Such a classification system may be of value in determining which patients may 
benefit from an endoscopic third ventriculostomy (ETV).  
Management of Hydrocephalus 
Patients with hydrocephalus may present with nausea, vomiting and headaches; the 
triad hallmark of raised intracranial pressure. Headaches are typically frontal, but may 
involve the whole head, predominantly occurring in the early morning and often 
exacerbated by recumbancy. Some relief is gained from analgesia. In the child whose 
skull sutures have yet to fuse, the head circumference grows and many of the 
symptoms and signs of raised ICP may not be as obvious as in adults. Similarly, the 
presence of papilloedema is observed more commonly in the adult with 
hydrocephalus.57 
The mainstay of investigation is a computed tomogram (CT) scan of the brain; which 
typically reveals ventriculomegaly, evidence of extraventricular fluid shift and loss of 
the surface sulcal CSF spaces. The aetiology of the hydrocephalus may also be 
determined, (e.g., posterior fossa lesion.) The CT scan allows for the assessment of 
the suitability and safety of lumbar CSF sampling. For further radiographic evaluation 
a Magnetic Resonance Image (MRI) scan will aid in defining lesions more accurately. 
Infective aetiology may be proven with use of lumbar puncture and CSF analysis. 
Similarily, an air-encephalogram may be useful in determining the communicating 
nature of the hydrocephalus.22 
Since antiquity the treatment of hydrocephalus has involved a surgical intervention, 
and this currently remains standard practice.  Hippocrates first described trephination 
and decompression for the treatment of this condition. Dandy is credited with 
attempting amongst the first ‘internal bypasses’, termed third ventriculostomy. These 
were undertaken via open craniotomies or using cystoscopes. The success rates were 
generally not high, and alternative interventions were sought.27 
The 1950’s saw the development of plastic and silicone tubing that allowed for the 
development of the valved shunt. CSF was diverted from the ventricular system to an 
alternative absorptive cavity. CSF shunting with modern materials is the standard 
treatment for hydrocephalus today.51 
The value of ventriculoperitoneal shunts (VPS) is well established. However, 
complications from their use are common, and particularly so for children. The 
incidence of insertion for new VPS in the United States is 5.5 per 100,000 per year, 
with children representing one-third of cases.68 Multiple causes exist for shunt 
malfunction, including obstruction, infection, disconnection, mechanical breakage and 
over-drainage, with lower socio-economic status being an independent risk factor for 
shunt dysfunction.68 The failure rate is noted to be the highest in the first year after 
insertion, with 40% at year one and 50% before the second year.13 Overall, between 
45% – 59% of all patients will require a shunt revision.68  
Given the high complication rate associated with VPS, an alternative CSF diversion 
strategy that does not require mechanical implantable materials is desirable. The 
advantages of rendering a patient shunt free have been widely propagated. It has been 
suggested that the Endoscopic Third Ventriculostomy (ETV) should be the first line 
therapy in non-communicating hydrocephalus, with advocates arguing for its use in 
cases of communicating hydrocephalus as well.11 27Warf e al. recommend that ETV 
should be first-line therapy for hydrocephalus in the developing world.66 
The complications associated with ETV are predominantly the intraoperative risks, 
which are higher than those of routine VPS placement.27 The initial risks, however, 
need to be balanced against the long term complications of shunt placement.  
Garton et al. undertook a cost effectiveness analysis of ETV where they compared a 
matched cohort of children undergoing an ETV or CSF shunt placement for 
hydrocephalus. This analysis compared the effect of the two therapies by taking into 
consideration the resource use and an effectiveness measure (days free of 
hydrocephalus treatment) for each group. Their results indicate that the ETV group 
enjoyed slightly higher days free of treatment, yet the intervention was not 
significantly less costly.26 ETVs, as anticipated, required substantially higher initial 
resource use while shunt complications consumed resources at a later point. 
Endoscopic Third Ventriculostomy (ETV) 
ETV involves the creation of a direct communication through the floor of the third 
ventricle and the subarachnoid spaces of the interpeduncular cistern. This allows for 
the bypassing of an obstruction at the level of the aqueduct or the fourth ventricle. 
The primary indication for ETV is symptomatic obstructive hydrocephalus. 
Mixter performed the first ETV using an ureteroscope in 1923.27 The procedure did 
not become popular until improvements in lighting, optics and a reduction in the size 
of the apparatus. Improved technology has resulted in endoscopes that can be attached 
to powerful light sources, high definition cameras and recording equipment. Both 
rigid and flexible endoscopes are available, with multiple ports that facilitate the 
introduction of tools to perform tasks such as cautery, fenestration, ablation and 
biopsy. 
Preoperative planning 
Preoperative planning requires the use of imaging; in addition to CT scan a T2-
weighted midline sagittal MRI scan is helpful in evaluating the third ventricular floor 
anatomy and appropriateness of an ETV procedure.13 Pre-pontine space and basilar 
artery anatomy can also be assessed. CINE MRI sequences are sometimes used to 
evaluate CSF flow and site of blockage.59, 65 van Lindert et al. have described the 
minimal information that ought to be derived from imaging studies before 
undertaking an ETV. 
Table 2: Required information prior to performing an ETV 65 
Required information for ETV 
• Shape of skull
• Form and size of ventricles
• Position and size of the foramen of Monro
• Position and size of the interthalamic adhesion
• Mamillary bodies
• Dorsum Sellae and relationship to floor of the third ventricle
• Slope of the floor of the third ventricle
• Width of the prepontine cistern
• Basilar artery and relationship to the floor of the third ventricle
• Presence of space occupying lesion
• Presence of membrane in ventricular system and prepontine cistern
• Presence of anatomical variation
 
 
The ideal patient for an ETV has radiological imaging showing lateral and third 
ventricles which are enlarged and a fourth ventricle which is relatively normal – so 
called triventricular hydrocephalus. 
 
Procedure 
The patient is positioned supine, with the head in a neutral position. A burrhole is 
made anterior to the coronal suture in the mid-pupillary line, usually on the right-hand 
side.  Consideration must be made for anatomical variation. The entry point is 
intended to be an extension of the line from the foramen of Monro to the 
interpeduncular cistern. This allows for the correct trajectory for insertion of a rigid 
endoscope.17 Following durotomy and cortesectomy, a brain needle is passed, CSF 
delivered and sample collected. Taking note of the depth that the needle is passed 
before fluid returns and the pressure under which the fluid is expelled. A 0 or 30-
degree endoscope is passed under visualization into the frontal horn of the right lateral 
ventricle. The foramen of Monro is often visualized upon entry into the ventricle. The 
head of the caudate is situated laterally and the septum pellucidum is located 
medially. The choroid plexus of the lateral ventricle projects forward into the 
foramen, then turns posteriorly to lie under the roof of the third ventricle. The vein of 
septum pellucidum, located anteromedially, joins the thalamostriate vein, located 
posterolaterally, at the posterior rim of the foramen of Monro. The endoscope is 
passed through the formen of Monro into the Third Ventricle. The floor of the Third 
Ventricle should enter the visual field.  
 
Figure 1: Endoscopic view of the foramen 
of Monro, also visible fornix, choroids 
plexus, head of caudate and thalamostriate 
vein.17 
The floor is often thin due to long-standing raised intracranial pressure, allowing for 
visualization of the underlying anatomy, including the Basilar artery. Sometimes the 
floor may be opaque and thickened, or the CSF turbid, making visualization of the 
underlying anatomy more difficult.  
A stoma is created in the midline of the floor of the Third Ventricle, anterior to the 
Basilar Artery into the interpeduncular cistern. Generally the stoma is created with a 
blunt instrument (often the tip of the cautery stylet or balloon catheter), but techniques 
utilizing forceps, wires and laser have been described.17 A St Rose (figure 8) balloon 
is advanced through the fenestration and inflated with 0.6ml of air to dilate the stoma. 
One should assess whether Lilequist’s membrane (an arachnoid condensation 
traversing the upper dorsum sellae to anterior edge of mammillary bodies 29) remains 
intact, as this too would need to be fenestrated to allow for CSF passage to the SAS. 
Warmed Ringer’s solution is routinely used as irrigation fluid to clear minor 
haemorrhage and prevent the ventricular system from decompressing.64 If infusion 
pumps are used, the infusion rate is maintained at under 15ml/minute.35 
Flow of CSF through the stoma, and pulsation of the floor of the third ventricle 
suggests a successful procedure. The endoscope is then removed, followed by a 
watertight dural closure, layered scalp wound closure and an external ventricular 
drain (EVD) is left in situ. Placement of an EVD is not universally undertaken, but is 
common practice in our institution. 
Complications of ETV 
Complications from ETV range from 0% to 15%, with a 1% mortality rate.17 55 
Intraoperative complications include; minor hemorrhage from the endoscope tract that 
usually abate spontaneously or after irrigation, or more rarely hemorrhage from the 
perforating branches may require endoscopic coagulation. Bradycardia can develop - 
this is thought to be a result of disturbance to the hypothalamic nuclei located in the 
floor of the third ventricle. Normal cardiac rhythm usually commences after removal 
of balloon compression.18 Early postoperative complications include CSF leak, 
ventriculitis and stomal closure. Kombogiorgas and Sgouros have found that CSF 
leak was adversely associated with ETV success. 40The development of basilar tip 
traumatic pseudoaneurysms may warrant endovascular or microsurgical attention. 
Restenosis is the most frequent late complication.18, 55 Seizure incidence following 
ETV is approximately 1%. 14Hypothalamic and fornix injury results from endoscope 
movement and may present with endocrine deficits and short-term memory loss. 3, 55 
The entity late rapid deterioration after ETV is estimated to occur between 1% – 2% 
of ETVs and is usually fatal. 15 
Postoperative period 
Patients are assessed clinically for signs of raised ICP suggestive of ETV failure; 
many institutions routinely place external ventricular drains to directly monitor 
intracranial pressure.  
Assessment of success may be difficult to prove, as ventricular size does not readily 
decrease, despite a functional ETV and symptom resolution in many cases. The 
definition of successful ETV varies in the literature, but mostly involves the 
avoidance of a subsequent surgical procedure for definitive CSF diversion or death 
related to hydrocephalus within six months of the procedure.36 Failure of ETV 
appears to be more common early post procedure, (i.e., within six months) than late. 
This is thought to be as a result of the patient’s CSF physiology being unfavourable 
for ETV.21 
Nevertheless, success rates for ETV are between 60% to 90%, with a plateau between 
60% - 75% in the long term.17336 Higher ETV success rates are observed for 
hydrocephalus as a result of aqueduct stenosis than for post-infectious, post-
hemorrhagic, meningomyelocoele and VPS failures.41 A repeat ETV following stomal 
closure has a success rate of up to 50%. Commonly associated risk factors for failure 
include history of CSF infection, previous VPS and age under six months.36 Age is 
the strongest independent predictor of ETV success, with age under six months the 
lowest ETV predicted success.36 If failure occurs, there is a cumulative probability of 
90% that the failure declares itself during the first 16 days after surgery.54 
 
Intracranial pressure monitoring can be achieved by transduction of an indwelling 
external ventricular drain (EVD) that is placed at operation, or via a dedicated ICP 
monitor probe. Advantages of the EVD include the ability to perform CSF removal 
and sampling (allowing for a measure of safety should the stoma occlude acutely), 
with a distinct disadvantage being the concern for ventriculostomy related infections 
(VRI). The risk of ventriculomeningitis associated with ICP monitoring via an EVD 
ranges between 0% to 22%.46    
Much debate exists in the literature with respect to prophylactic catheter changes. 
Mayhall et al reported a reduced rate of infection in patients in whom the ventricular 
catherter was routinely changed after five days. 47 Recent metanalysis have proven no 
increased risk of infection beyond five days, and recommend against prophylactic 
changes. 30 Dedicated ICP monitoring has a negligible risk of the development of 
meningitis, irrespective of whether the probe is placed intraparenchymally or via a 
subarachnoid bolt. Drainage of CSF from the ventricular catheter is also not 
associated with a higher incidence of ventriculitis.47 
Early ETV failure may be as a result of failure of CSF absorption rather than closure 
of the stoma. The clinical course immediately post ETV is highly variable with many 
patients experiencing short periods of intracranial hypertension. The interval between 
the creation of the stoma and the opening of the basal cisterns (closed due to raised 
ICP) has been termed the ‘adaptation period’. 31 The transient periods of raised 
pressure have often led practitioners to believe that the ETV had failed, and an 
alternative CSF diversion would be required. A number of hypotheses exist to explain 
the ‘adaptation period’; the chronic compression exerted on the basal cisterns from 
long-term raised ICP can cause a delay in the opening of the SAS 5 Alternatively, 
previously masked communicating hydrocephalus may now limit the resorption 
capacity for CSF.5, 56    
Postoperative imaging of ETV shows wide variability in the change in ventricular 
size. In general, should the ventricles decrease in size following ETV, this provides 
some evidence that the procedure has been successful. 53 In successful ETVs it has 
been noted that the ventricular size appears to decrease but will not reach normal 
equivalents.42 Often the third ventricle demonstrates a larger reduction in size than the 
lateral ventricles which differs between acute and chronic hydrocephalus. 42 The 
clinical significance of this ongoing ventriculomegaly is unknown, although some 
have suggested that the ETV has resulted in a compensatory communicating 
hydrocephalus.58 Ventricular size assessment should be considered a useful adjunct to 
the post-operative clinical assessment of patients, with rapid decrease in ventricular 
size not precluding the possibility of delayed ETV failure.  
Given the challenges with early radiological assessment and uncertainty of ETV 
failure or ‘adaptation period’, some authors have proposed the use of continuous 
lumbar drainage (CLD) following ETV. The proposed mechanism is based on the 
premise that absorption problems following ETV are temporary; many ETVs would 
be ‘successful’, if a safe strategy is used to facilitate this absorption. The lumbar drain 
is thought to have physiological advantages over an EVD, including encouraging flow 
across the stoma, washing out debris, blood and protein load. However, it is 
advocated that the CLD be utilized in conjunction with ICP monitor.49  
Prediction of Endoscopic Third Ventriculostomy Outcome 
ETV success has been defined as not requiring a ventriculo-peritoneal shunt in the 
long term.3, 9, 37 The success rates quoted in the literature are between 60% - 90%. 3, 17 
No technique has been shown to adequately demonstrate patentcy of the SAS – a vital 
factor in predicting positive ETV outcome.50 Given the uncertainty of an ETV being 
successful a number of modalities and techniques have been devised to predict the 
likelihood of ETV success. 
Intraoperative impression 
The use of clinical, aetiological and radiological data is utilised to make an 
assessment of the suitability of an ETV for the treatment of hydrocephalus, and 
inherent in this assessment, the prediction of success. During an ETV, the surgeon 
typically would take note of the size and position of the stoma created, thickness of 
the third ventricular floor, presence of adhesions, presence of intraventricular 
haemorrhage and CSF flow through the stoma. Zohdi et al. have suggested the “whirl 
sign”, a downward flow of CSF through the stoma could predict ETV success.69 
Kombogiorgas et al. in their series of ETVs assessed the following: i) relative stomal 
size, ii) intraoperative haemorrhage, iii) thick/ double third ventricular floor, iv) 
presence of adhesions, v) CSF flow through stoma, vi) aetiology of hydrocephalus, 
vii) shunt presence, viii) CSF infection or haemorrhage and x) previous ETV. Their
study did not demonstrate a correlation between adhesions, thickened floor and ETV 
 
success, but did suggest an association of success to patients without previous shunts, 
and stoma size. CSF leaks were strongly associated with failure. 40      
 
Greenfield et al, sought to devise a simple intraoperative assessment criteria to allow 
surgeons to predict ETV success without the need for postoperative monitoring and 
imaging. A scoring system that included age of patient (<2 years), neonatal IVH 
history, meningitis history or VPS infection, each contributed to a maximal 
preoperative score of 2. The intraoperative assessment involved, three categories 
Anatomy, Subarachnoid Space and CSF movement, each contributing one point. 
 
Table 3: Intraoperative Scoring Criteria 28 
Unusual Anatomy Subarachnoid Space Stoma 
Intraventricular scaring Presence of scaring Stomal CSF movement  





A maximal score of five, would be tallied at the end of the procedure, Grade 0 
patients have 95% ETV success rate, while patients with at least a Grade 3 have 100% 
failure rate.28 As the authors of the above analysis acknowledge, defining 
“reproducible objective measurements of features including CSF pulsation, 
subarachnoid scaring and anatomical variance” is difficult. 
 
 
The literature appears to be divided regarding the predictive power of the 
intraoperative impression during ETV; hence recommendations calling for further 
blinded prospective trials to be undertaken.16  
 
Hydrostatic Pressure Testing 
The mobility and pulsatility of the floor of the third ventricle after stoma creation is 
thought to be an indication of procedure success. Kamel et al, undertook a simple 
investigation to assess the mobility and flow through a newly created stoma. Once a 
stoma was created the irrigating solution was set at 30cm above the external auditory 
meatus and the valve opened for 10 seconds, all ports on the endoscope were closed. 
The floor of the third ventricle ballooning downward would accompany good flow 
through the stoma. Once the irrigation was stopped and ports opened, reverse flow 
would cause an upward displacement of the floor. These outcomes would score a 
positive hydrostatic test. The authors report a test sensitivity 95.24%, specificity 
66.67%, positive predictive value 86.96% and negative predictive value 85.7%. Their 
sample had an ETV success rate of 70%, which was significantly higher in patients 
with a positive hydrostatic test (p <0.05). The hypothesis for a mobile floor 
correlating with a successful ETV is i) a mobile floor represents a dilated third 
ventricle with a pressure differential between the third ventricle and the subarachnoid 
space, and ii) good flow through the stoma i.e., functional stoma.37 The hydrostatic 
test does not provide insight into the absorptive capacity of the subarachnoid space, 





Intracranial Pressure Monitoring 
Many authors have suggested that an accurate assessment of the function of the ETV 
stoma and subsequent ‘opening up’ of the subarachnoid reabsorptive pathways can be 
deduced from ICP measurement. 23, 27, 31 The most reliable means of detecting 
recurrent hydrocephalus following ETV is through formal ICP monitoring.1 The 
principle purpose of ICP monitoring is to ascertain if there is development of the 
‘adaptation period’, where previously compressed basal cisterns begin to allow the 
passage of CSF for convexity absorption. Commonly, intracranial pressure is 
monitored via ventricular ICP probes or transduced through closed external 
ventricular drains.5, 10, 50 More recently studies have described the use of telemetric 
ICP monitoring systems following ETV.67 The claimed benefits being longer term 
pressure monitoring and little restriction on patient mobilization.  
 
Repana et al demonstrated that, following ETV, up to 50% of their patients have 
transient ICP rises which were responsive to CSF removal. They also noted that 
variable ICP patterns occurred among groups of patients. Raised ICP episodes are 
clustered within the first two days postoperatively. Patients presenting with shunt 
malfunction or intraventricular lesions tended to develop the most severe intracranial 
hypertension following ETV. ICP monitoring in such patients is recommended by this 
group. However, Rapana was unable to assign predictive value to the different 
postoperative ICP patterns.50 
 
Four groups were identified, each with their own ICP characteristics: 
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Rapana et al concluded, “no relationship could be established between post operative 
ICP course and late outcome.” 
 
Cinalli et al recorded ICP in 64 children following ETV for an average of seven days 















• ICP remained 
within a 3mm Hg 
range throughout 
monitoring period 




• After an initial 
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The higher incidence of  “Secondary Rise” and “Progressive Increase” patterns in the 
Failed ETV group compared with the Successful ETV group is statistically 
significant. (P = 0.01) This suggests that there is some predictive quality to these ICP 
Trend Patterns. However, the authors make note that high ICP in the first 
postoperative days (with or without symptoms and signs of raised ICP) may not be 
related to failure of the ETV, but rather a transient phase.10 
 
Table 6: ICP Trend Patterns Relating to ETV Success 10 
ICP Trend Patterns Successful ETV Failed ETV 
Progressive Decrease 27 (56%) 2 (15%) 
Stable 7 (15%) 0 (0%) 
Progressive Increase 0 (0%) 3 (23%) 
Secondary Rise 14 (29%) 8 (62%) 
Total 48 patients 13 patients 
  
 
Cinalli et al. go on to conclude that a cycle of one to three lumber punctures should be 
performed before deciding that ETV has failed and that shunting is required. 
 
Currently, it is not clear that ICP pressure patterns are useful in differentiating 




Strong and independent predictors of ETV success include age, aetiology, and 
presence of previous shunt.41 Age, appears to be the strongest predictor, infants 
younger than six months having the lowest predicted ETV success. Kulkarni et al. 
developed an ETV Success Score (ETVSS) that approximates the probability of 
successful ETV. (Table 7) Later work by Kulkarni et al. has shown that favourable 
ETVSS scores (>=80) predict ETV failure rate being lower than that of shunt failure, 
and patients with less favourable scores (ETVSS <= 70) have ETV failure risk 
initially higher than shunt risk, but lowering between 3-6 months after surgery.43  
 
ETV Success Score = Age Score + Aetiology Score + Previous Shunt Score ! 




Table 7: ETVSS Scoring Criteria 41 
Score Age Aetiology Previous Shunt 
0 < 1 month Post-infectious Previous Shunt 
10 1 month to < 6 
months 
 No Previous Shunt 











40 1 year to 10 years   
50 > 10 years   
 
 
The scoring system has been criticized by colleagues, as representing what is already 
known. By definition patients with high ETVSS are older than 1 year, likely to carry 
the diagnosis of aqueducal stenosis or a tectal glioma. Infants under one year are 
unable to have high ETVSS.12 
 
 
An alternative scoring system was developed at Cure Children’s Hospital for Uganda 
(CCHU), the ETV Success Score, with ranges from 0 (least likely to succeed) to 9 
(most likely to succeed). (Table 8) 
Table 8: CCHU ETV Success Score Criteria 66 
 
Although the Hosmer-Lemeshow statistic was not significant when validating the 
model, the CCHU ETV Success Score was able to stratify into high, moderate and 
low chance of ETV success.66 The authors noted that early success of ETV forecasts a 
high chance of long-term success. In their series successful ETV at 6 months was 
associated with a 3-year success rate of 95%.66 One must, however, consider the 
differences in the Ugandan hydrocephalus population before applying the CCHU 
ETV Success Score in other geographies. 
 
Kehler and colleagues proposed another attempt at a semi-quantitative predictive 
system. Criteria measured include; i) extent of the bulge of floor of the third ventricle, 
  Score 
< 6 Months 0 
6 Month – 1 year 1 
Age 






Partial /Unilateral 2 
Choroid Plexus 
Cauterization 
Complete / Bilateral 4 
 
ii) presence of visualized CSF pathway obstruction at MRI imaging and iii) the 
progression of clinical symptoms. Five grades are assigned; retrospective analysis 
showed that ETV success (or failure) was correctly predicted in 40% (Grade 3), 58% 
(Grade 4) and 95% (Grade 5).38 
 
No scoring or grading system appears to have the predictive quality that would give 
operators full confidence around the future success of the ETV.   
 
 
Cine phase-contrast MRI 
Conventional spin-echo MRI has been utilized to demonstrate a CSF flow void at the 
anterior/inferior border of the third ventricle following ETV. The flow void in the T2 
weighted images caused by rapid turbulent flow, indicate a functioning 
ventriculostomy. Absence of the void does not preclude a functional ETV, and 
interference from basilar artery pulsation may affect interpretation.33 Quantitative cine 
phase-contrast MRI allow for time-resolved measurement of flow via anatomic 
structures; arteries, veins and CSF spaces. The cine format is sufficient for measuring 
patency – it is, however, subjective.45 Measuring velocities at multiple sites provides 
additional physiologic and prognostic information.45 Velocity encoded images are 
obtained by acquiring an imaging parallel to the floor of the third ventricle that 
focuses on the ventriculostomy. Velocity encoding is usually set at between 10 – 20 
cm/sec and applied in three orthogonal directions. Axial analysis allows for 
quantitative CSF flow dynamics to be studied, while a mid-sagittal analysis provides 
good qualitative assessment. 2 
 
 
During CSF diastole, CSF moves in a caudocranial direction (termed positive 
velocity), in CSF systole, flow is craniocaudal (negative velocity). The CSF stroke 
volume is the net CSF volume inflow and outflow during cardiac cycle.2 
 
Flow across the ventriculostomy and the flow rate measurement has become an 
outcome measure in and of itself – with success of ETV assessed with flow MR 
studies. Active pulsatile flow is seen as confirmation of ventriculostomy function.59 
Fukuhara et al conclude that a cine PR MR image studying flow of CSF is highly 
reliable for detecting ETV obstruction and patency. Minor flow in the third ventricle 
should be considered an early sign of obstruction.25 In 85%-100% of clinically 
improved patients, there is evidence of flow through the ETV site.42 However, even in 
clinical failures patency of the ETV has been shown, up to 50% in some series.9 
Stivaros et al. in a pilot study of thirteen patients proved that an ETV induces changes 
in brain volume and cerebral blood flow (CBF). However, they also note that there is 
no literature support of changes in CBF and improved clinical outcome.59 
 
Bargallo et al concluded that stroke volume quantification is a good indicator of ETV 
function and that overall flow magnitude (systolic stroke volume + net diastolic stroke 
volume) was the most effective variable determining which patients would improve 
after surgery. (Values >75mm3 showed a sensitivity 76.7%, specificity 87.5%)2 
 
With regard to long term follow up, Faggin et al, have concluded that Cine phase-
contrast MRI “has a high capacity to detect a flow defect through a ventriculostomy, 
raising the suspicion of ETV failure.”19 The data presented remains insufficient to 
 




Under normal metabolic conditions, radioisotope tracer injected into the subarachnoid 
space passes up to the basal cisterns within 1 hour, sylvian fissure by 2 to 6 hours and 
over the convexities by 12 to 24 hours.48 Radionucleotide cerebrospinal fluid 
scintigraphy (RCFS), is said to have the advantage over CT and MRI scans by being 
able to differentiate between communicating and non-communicating 
hydrocephalus.21 Diethylenetriamine pentaacetic acid (DTPA), a radioisotope, 
degrades from 4 to 6 hours, with minimal remaining after 48 hours. The DTPA counts 
are obtained by a gamma camera and a C48:C5 ratio is calculated. Normal adult 
C48:C5 ratio is less than 0.35.48 In their study, Nishiyama et al. showed images 
obtained at 5 hours demonstrated a higher radioisotope activity in the ventricles at 6 
months compared to 1 week post-ETV. 48-hour images revealed decreased persistent 
radio-isotope at the convexities from 1 week to 6 months after ETV.48 The literature 
reveals that some authors suggest cisternography should be performed prior to 
ventriculostomy, ensuring that CSF absorption mechanisms are intact, however this 
does not appear to be common practice nor practical.34  
 
Intraoperative ventriculo-stomographic evaluation 
Intraoperative ventriculo-stomography (IOVSG) is a technique that allows the 
confirmation of adequacy of the endoscopic procedure during surgery. The infiltration 
of radio-opaque contrast (commonly iohexol – due to its limited neurotoxic effects) 
via a working channel of an endoscope into the ventricular system is assessed with the 
 
aid of an image intensifier. Typically images are acquired at 1, 3, and 5-minute 
intervals, tracing the flow of contrast into the SAS. Husain et al define stoma 
functionality as good (rapid transit, <1 minute), fair (transit 1 – 3 minutes) or poor 
(retention of contrast in cisternal spaces > 3 minutes). Patients with poor functionality 
would be planned for VPS.32 The authors suggest the use of this technique to assess 
obstruction site, CSF dynamics and functional status of ETV.32 
 
Outflow resistance and elastance 
A Swedish study61 undertook to assess the correlation between clinical outcome after 
ETV and resistance to outflow of CSF and elastance. These parameters can be 
measured by bolus injection, constant flow rate infusion or constant pressure infusion. 
The day prior to ETV, an EVD catheter is placed into the ventricle, connected to a 
pressure transducer, and the burrhole then closed with silicone plug and tisseel. 
Infusion tests are conducted with dedicated software to analyse the ICP response. The 
intraventricular Outflow resistance (Rout) and elastance can be calculated. After 
several hours of data collection, an ETV is performed. After the ETV, Rout was 
decreased as compared with the values of the two preoperative compartments. The 
decrease of Rout correlated with the clinical improvement of the patients. The decrease 
in Rout might reflect the increased area of CSF absorption in both the SAS and the 
ventricles. Preoperative elastance correlated positively with clinical improvement, but 
elastance was unchanged after ETV. The preoperative values of Rout-SAS and Rout-IV 
do not predict patient outcome after ETV in adults with hydrocephalus due to 
aqueduct stenosis.61 Hence, it appears that Rout and elastance are insufficient measures 
to predict success of ETV. 
 
 
Transcranial Doppler Sonography  
Transcranial Doppler sonography (TCD) has been developed to detect the changes in 
cerebral blood flow velocities. It is a non-invasive, risk-free, easily repeatable 
technique that can be performed at the patient’s bedside.  A TCD is measured 
transtemporally with an ultrasonic transducer over the middle cerebral artery (MCA). 
The mean flow velocity (mFV) is assessed from the resulting graphic trace. Pulsatility 
Index (PI) is a derived value from the difference in the flow velocity divided by the 
mFV. 
 
Bellner et al. showed in their study of eighty-one patients that there is a strong 
correlation (correlation coefficient 0.938) between ICP and PI.4 Further more, 
preliminary data, from a study by Vajda et al. suggested that the PI is a useful non-
invasive tool for determining the patency of fenestration following ETV in the early 
follow-up period.63 They conclude that the TCD-defined PI is “a very sensitive 
diagnostic tool in the follow-up patients who required a 3rd ventriculostomy.” Results 
showed a decrease in the PI immediately following ETV and on the fifth post-
operative day in all patients with a functioning stoma. However, their study has been 
criticized for the short post-op period of analysis (five days). Nevertheless, TCD in 
conjunction with a clinical assessment may well prove to be a useful non-invasive 
method to evaluate stoma patency.  




Table 9: Summary of Pertinent Literature Review 
Modality Author Publication 
Date 
Study Design Sample 
Size 






618 Children ETVSS devised that can identify 
children likely to have successful 
ETV  






Children Risk of ETV failure is progressively 
lower than risk of VPS failure with 
increasing time from surgery. 










Warf 2010 Prospective 
cohort study 
979 Children CCHU ETVSS predicts chance of 
ETV success in children with 






Velocity ratio between pontine 
cistern and spinal cord can help 
determine functional status of third 
ventriculostomy. Pulsation from 
basilar artery may interfere with 
interpretation.  




Cine PC MR imaging is reliable for 
detecting patency of third 
ventriculostomy. Minor flow should 

















Cinalli 1999 Retrospective 
study 
213 Children Midline sagittal T2 weighted MR 
with CINE PC MR provide reliable 
tool for diagnosis of aqueductal 
 
stenosis and stoma follow-up 
evaluation 
Kulkarni 2000 Prospective 
study 
29 Children Ventricular size reduces in 
successful and failed ETV. 
Reduction significantly greater in 
success. Flow void correlates with 
clinical success. 




Quantification of stroke volume at 
ventriculostomy is a good indicator 
of ETV functional status. High 
stroke volume is a positive 
predictor of ETV success 
Stivaros 2009 Prospective 
study 
13 Adults ETV induces changes in brain 
volume and CBF 
 
Faggin 2011 Retrospective 
study 
84 Children Intraoperative observation of 
thickened arachnoid and 
decreasing flow on routine Cine 
MR are significant risks for 
deterioration. Cine MR has high 
capacity to detect flow defect 




PI useful in evaluating patency of 


























Strong correlation between PI and 
ICP demonstrated, independent of 























videos of ETV 
33 Children No correlation between pre-pontine 
adhesions, double or thickened 
third ventricle floor and ETV 
success. Stoma size may correlate 






videos of ETV 
33 Children No correlation between pre-pontine 
adhesions, double or thickened 
third ventricle floor and ETV 
success. Stoma size may correlate 



















Intraoperative assessment more 
reliable than post ETV MRI and 
EVD monitoring. Grading scale 















Positive test confirms adequate 
flow through stoma. Stoma mobility 
important predictor of ETV 
success. 




CSF dynamics convert from shunt 
dependant to shunt independent 
state within 1 week. Absorptive 
capacity through SAS my show 

























Only cases with open cisterns 
should be considered for RC. 
Mortality 1%, Neurological deficit 
























IOVSG is simple and safe, 
confirms adequacy of ETV during 

























 Tisell 2002 Propspective 
study 
15 Adults Resistance could not predict ETV 
outcome. Reduction in resistance 
correlated with clinical 
improvement. Pre-operative 





Frim 1997 Case study 1 Adult Reduction in ICP post ETV 
documented after initial period of 
acclimation 
Bellotti 2001 Prospective 
study 
10 Adults Postoperative ICP monitoring 
provides useful information to 
determine correct stoma 
functioning in early postoperative 
period 
Rapana 2004 Prospective 
study 
26 Adults Unable to assign predictive value 
to different postoperative ICP 
patterns. Patients with VPS 
malfunction and intraventricular 
mass lesions show higher 










Cinalli 2006 Prospective 64 Children High ICP early post-ETV probably 
related to slow permeation of SAS. 
Lumbar puncture probably 
decreases CSF outflow resistance. 
Cycle 1 – 3 LP should be 
performed before ETV assumed to 
have failed 
 
Part C: Manuscript 
Abstract 
Objectives: Endocscopic third ventriculostomy (ETV) is a routinely utilized 
alternative to ventriculoperitoneal shunt (VPS) in obstructive hydrocephalus. We 
attempt to determine the usefulness of the surgeon’s intraoperative impression and 
early postoperative period intracranial pressure monitoring that may help guide 
clinicians in predicting the functional outcome of ETV.    
Methods: The patients who underwent ETV between 2006 and 2011 were 
retrospectively reviewed. The sample included sixty-three patients, 23 female and 40 
male, between the ages of 13 and 69. In each case the surgeon’s intraoperative 
impression, cerebrospinal fluid (CSF) samplings and post-operative intracranial 
pressure (ICP) monitoring (via transduced external ventricular drain for seventy-two 
hours) was recorded and evaluated in light of functional outcome of ETV at discharge 
and early followup. (1-2 months) 
Results: ICP monitoring predicted initial function of the ETV in 51 cases (80.9%) and 
in 12 cases (19%) suggested ETV failure. Monitoring has a positive predictive value 
(PPV) of 76.3% and a negative predictive value (NPV) of 100%. While the surgeon’s 
intraoperative impression of future function has a PPV of 76.5%, and NPV of 76.9%. 
CSF sampling has a much poorer predictive quality owing to the wide confidence 
interval and a PPV of 63.6% and NPV 38.2%. In our series the evidence of sepsis as a 
result of EVD was found to be 11.67%.  
Conclusions: ETV is a valuable means of treating obstructive hydrocephalus. By 
considering the surgeon’s intraoperative impression and post-operative ICP 
monitoring course some of the uncertainty around its functional outcome can be 
 
overcome. The surgeon’s impression and the ICP monitoring offer approximately the 
same predictive quality for ETV outcome. 
Key Words 
Endoscopic third ventriculostomy (ETV), Hydrocephalus, Outcome ETV, Intracranial 
pressure (ICP) monitoring 
Introduction 
Endoscopic third ventriculostomy (ETV) is increasingly employed as the first-line 
treatment for non-communicating hydrocephalus.10, 15, 17, 44, 63, 66 The procedures high 
success rate and limited complications make it an attractive option. 3, 15, 24, 36, 43, 55, 61 
However determining if the procedure is likely to be successful can be difficult.9 
Many approaches to this problem have been sought; none yet providing adequate 
predictive quality for routine practice.37, 65 Radiological studies of ventricle size are 
recognized to be inadequate to infer ETV success, MRI assessment of flow across the 
ETV stoma has been demonstrated to be present in clinically proven failures.2, 19, 21, 25, 
29, 42, 45, 53, 59 Invasive ventriculographic studies have a role to play but are not without 
complication and are cumbersome when compared to what is otherwise an elegant 
procedure.32 Non-invasive testing with transcranial dopplers shows promise; but 
insufficient study exists to consider it for routine clinical application.61, 63 Intracranial 
pressure monitoring remains an acknowledged means of determining ETV function 
and a proxy to inferring sub-arachnoid space (SAS) absorptive function.5, 10, 50, 67 This 
study has been undertaken primarily to assess value of post-ETV ICP monitoring in 
predicting the early outcome of ETV. In parallel, the surgeon’s intraoperative 
impression on the future function of ETV is evaluated and compared to the post-
 
operative ICP monitoring results. Cerebrospinal fluid (CSF) sampled at the time of 
ETV is also evaluated for its predictive quality on future ETV function. 
Clinical Materials and Methods 
Patient Population 
Sixty-three patients aged between thirteen and sixty-seven years who underwent ETV 
for hydrocephalus between January 2005 and July 2011 were studied. The mean age 
of the studied population was 41.28 years, comprising 23 females (36.5%) and 40 
males (63.49%). 
The range of pathology is displayed in Table 1 below: 
 
Table 1: Sample Population Aetiology 
Aetiology of Hydrocephalus Number Percentage 
Congenital 4 6% 
Haemorrhage 4 6% 
Infective – Bacterial 5 8% 
Infective – Tuberculous 8 13% 
Infective – NOS 6 10% 
Tumour – Posterior Fossa 23 37% 
Tumour – Supratentorial 3 5% 
Other1 10 16% 
Total 63 100% 
 
                                                
1 Other includes conditions where aetiology is unknown (n=5) with VPS dysfunction (n=2), Ventriculo-atrial shunt dysfunction 
(n=1), previous ETV (n=2) 
 
For fifty-seven patients (90.5%) the studied procedure was their index ETV, and in 10 
patients (9.5%) the procedure was a repeat ETV. Patients were followed up at the 
Neurosurgical outpatients department between one and three months post-discharge. 
Follow up rate were generally poor, (Table 2)  
 
Table 2: Patient Follow Up 
Data at Follow Up Follow Up 
Died 6 (9.5%) 
Data available 50 (79.4%) 
Lost to follow up 7 (11.1%) 
   
Patient Evaluation and Therapy 
Patients were all admitted under Neurosurgical care to a single tertiary hospital that is 
a referral center for a population of approximately 10 millions people2. 
Hydrocephalus was diagnosed in all patients by Computed Tomography and/or 
Magnetic Resonance scans. In many patients there were symptoms or signs of raised 
ICP. Cine phase MRI is not common practice in our institution, and was not 
performed. 
 
The decision to perform an ETV was taken upon review of the radiology by 
consensus among the consultant staff of the Neurosurgical unit. Depending on the 
urgency, the patients were prepared for surgical procedure for the same day or next 
elective slate. In our series, multiple surgeons performed the ETVs, with the senior 
consultant present in the majority of cases. 
                                                
2 Census 2001, Stats SA. Western Cape 4524336, Eastern Cape 6436763 
 
 
Equipment utilized and procedure method 
A 6mm rigid endoscope and stack (Storz and co., Tuttlingen, Germany) was used for 
all cases. A burrhole was created in the mid-pupillary line anterior to the coronal 
suture and an ETV performed via ipsilateral ventricle with perfusion of warmed 
Ringers solution. A CSF sample was taken prior to insertion of endoscope; care 
would be taken to ensure minimal loss of CSF. The endoscope was utilized to identify 
the foramen of Monro, through which the endocsope was advanced. Entry into the 
third ventricle allowed for fenestration of the floor with the aid of monopolar cautery 
probe or balloon catheter. The stoma was dilated by inflation of a St Rose figure of 8 
balloon with 0.6ml of air. Once the stoma was created, the endoscope was advanced 
through to visualize the Basilar artery and pontine perforators. Care was taken to 
ensure that perforation through Liliequist membrane had been achieved. 
Haemorrhage, when it occurred, was treated by continuous wash with warmed 
Ringers solution. After the endoscope had been removed a standard ventriculostomy 
drain was placed in the lateral ventricle via the tract and secured to the scalp. A 
drainage bag was attached, and the system remained clamped. 
 
Findings and surgical notes 
The operator would make note of the intraventricular environment, including the 
clarity of the CSF, thickness of the third ventricular floor, presence of membranes 
(synaechiae), pulsatility of floor, flow through stoma and anatomical variations. Note 
would also be made of any intraoperative complications from the procedure; incorrect 




Post-operative management and monitoring 
All patients were then transferred to the Neurosurgical Highcare or ICU. The EVD 
would be connected, in an aseptic fashion, by the nursing staff to a TruWave 
Disposable Pressure Transducer. ([PX260], Edwards Lifesciences, Irvine, Ca.) Care 
was taken to avoid loss of CSF at time of connection to the transducer. The catheter 
remained clamped and the transducer attached to a Nihon Kohden Lifescope Bedside 
Monitor ([MU-651RK], Nihon Kohden Corporation, Tokyo, Japan.) The apparatus 
was zeroed with the transducer at the level of the tragus, and the transducer secured. 
Graphic trace and numerical data would be continuously displayed on the monitor 
with recordings manually captured every thirty minutes for the first two hours 
postoperatively and hourly thereafter. Intracranial pressures were displayed in 
millimeters mercury. Decisions were taken based on the patient’s clinical condition, 
ICP readings and radiology (when requested). Sustained high ICP readings (more 
than fifteen minutes), may have warranted CSF release, this would be performed via 
lumbar puncture and/or opening of the EVD.  
 
The data collected for analysis was captured from the ICU nursing charts that reflect 
the ICP values as recorded by the unit’s staff.  Data captured included the maximal 
ICP, daily ICPs (taken consistently at the same time each day) and CSF release 
mechanism, if undertaken.  
 
 
Table 3: Duration and Number of Monitored Patients Post-ETV 
Hours Monitored Number Percentage 
48 15 23.8% 
72 43 68.3% 
96 4 6.3% 
120 1 1.6% 
 
In the majority of cases the monitoring was performed for 72 hours. Thereafter the 
EVD was removed, scalp closed in the standard fashion and the patient transferred to 




Analysis of the data was performed utilizing Stata IC version 12.0 (StatCorp LP, 
College Station, TX, US), statistical software. Monitoring predicted function of the 
ETV in 51 cases (80.9%) and in 12 cases (19%) suggested ETV failure and these 
patients went on to have a VPS. When ETV function was evaluated at the initial 
follow up, the monitoring predictive quality resulted in a positive predictive value 
(PPV) of 76.3% and a negative predictive value of 100%. 
 
Intraoperative impression was classified into positive expectation of ETV function 
(n=44), negative expectation (n=19) and uncertain (n=11).  The intraroperative 
impression has a test PPV of 76.5%, and negative predictive value (NPV) of 76.9%. 
 
 
CSF as a predictive test for ETV function, as anticipated, is of little value. At initial 
follow up the test shows a PPV of 63.6% and NPV 38.2% with wide confidence 
intervals. 
 









Sensitivity Specificity ROC area 
(AUROC) 
 76.3% 100% 100% 57.1% 0.786 
59.8% 75.3% 88.1% 34% 0.667 
Monitoring 
95% CI 
88.6% 100% 100% 78.2% 0.894 
 76.5% 76.9% 89.7% 55.6% 0.726 





89.3% 95% 97.8% 78.5% 0.857 
 63.6% 38.2% 40% 61.9% 0.51 
40.7% 22.2% 23.9% 38.4% 0.375 
CSF 
95%  CI 
82.8% 56.4% 57.9% 81.9% 0.644 
 
Table 5: ETV Function at Discharge and Follow Up 
ETV Function Data Discharge Follow Up 
ETV functional 51 (81%) 29 (58%) 
ETV non-functional 12 (19%) 21 (42%) 




Table 6: Aetiology and ETV Function at Follow Up 
ETV Functional 
Follow Up Aetiology of Hydrocephalus 
Number Percentage3  
Congenital 1 33.3% 
Haemorrhage 3 75% 
Infective 10 62.5% 
Tumour – Posterior Fossa 2 66.7% 
Tumour – Supratentorial 5 35.7% 
Other4 8 80% 
Total 29 58% 
 
A consequence of post-operative monitoring is the need for either a dedicated 
pressure transducer or a transduced external ventricular drain; concern exists about 
the risk of infection posed by these devices. In our study we noted an infection rate 
related to EVD of 11.67%. This is consistent with findings in the literature, of 
ventriculostomy related infections rates between 0 – 22%.46, 47 
 
Patients underwent CSF release if the monitoring reflected prolonged raised ICP 
and/or the clinical picture suggested intracranial hypertension. 58% of patients did not 
require any form of CSF release, 9.7% required a single CSF release and 32% 
required multiple CSF subtractions.    
 
                                                
3 Reflects the proportion of successful ETVs out of the proportion of ETVs performed in that aetiology category  
4 Other includes conditions where aetiology is unknown (n=5) with VPS dysfunction (n=2), Ventriculo-atrial shunt dysfunction 
(n=1), previous ETV (n=2) 
 
Table 7: CSF Release 
CSF Release No. Percentage 
None 36 58.1% 
Single 6 9.7% 
Multiple 20 32.3% 
 
The release mechanism was via Lumbar puncture (n=9, 34.6%), EVD (n=14, 53.9%) 
and both Lumbar Puncture and EVD (n=3, 11.5%) 
 
Table 8: Release Mechanism 
CSF Release Mechanism No. Percentage 
Lumbar Puncture 9 34.5% 
EVD 14 53.9% 
Both 3 32.3% 
 
The monitored population who underwent CSF release were analysed to ascertain if 
there was a predictive quality to action of CSF release on the outcome of the ETV at 
follow up. Results indicate that there is little predictive quality in favour of a positive 
or negative predictive outcome. 
 
 









Sensitivity Specificity ROC area 
(AUROC) 
 40.9% 25.9% 31% 35% 0.33 





63.6% 46.3% 50.8% 59.2% 0.467 
 
The risk of EVD related sepsis was reviewed in the context of CSF release, to 
determine if the action of CSF removal contributed to development of sepsis. A 
Fisher’s exact test was performed, which returned a value of 1.0, indicating that there 
was no correlation, in our sample, between CSF removal and EVD related sepsis. 
This result needs to be interpreted in light of the fact that 7 (11.67%) patients in the 
sample had evidence of sepsis.  
 
A subgroup analysis was performed to determine if there was correlation between age 
at time of procedure and function of ETV at follow up. The data was dichotomized to 
patients younger and older than 40 years. This age cut off was selected, as the mean 
age of the sample population was 39, mode 30 and median 37 years. The prevalence 
ratio of 1.26 in the age category 40 years and above was not significant (p=0.348), the 
odds ratio of 1.74 also was not significant (p=0.342). 
Similar analysis was undertaken for gender, revealing that males had a prevalence 
ratio of 1.35 with a p-value of 0.298 and an odds ratio of 1.97 (p=0.264). A 
prevalence ratio of 2.2 was noted for ETV success at follow up if CSF release was 
 
either taken on a single occasion or not performed, however, the result was not 
significant.  
 
 Table 10: Prevalence Ratio Analysis 
Follow Up Variable 
 No. % Success PR (95% CI) 
Female 17 47.1% 1.0 (ref) 
Male 33 63.6% 1.35 (0.77-2.39) 
Age < 40 27 51.9% 1.0 (ref) 
Age > 40 23 65.2% 1.26 (0.78 – 2.03) 
Multiple CSF Release5 18 33.3% 1.0 (ref) 
No Release5 27 74.1% 2.22 (1.11-4.41) 
Single CSF Release5 4 75% 2.25 (0.92-5.45) 
LP release5 8 75% 1.0 (ref) 
EVD release5  11 18.1% 0.24 (0.09-1.09) 
LP + EVD release5 3 33.3% 0.44 (0.09-2.14) 
 
Furthermore, the analyses of ETV success at follow up with respect to CSF release 
via LP, EVD or both did not reveal a statistically significant result, but did suggest 




                                                




Obstructive hydrocephalus remains the main indication for ETV, with this treatment 
an effective and safe alternative to VPS or other shunt procedures.8, 21, 31 Despite the 
recognized advantages of ETV, success rates in most series are between 60-90%.3, 17, 
49 Failures of ETV are documented to mainly occur early8, 26No technique has been 
able to prove patency of the SAS, a vital factor in predicting postive ETV outcome.50  
Numerous methods and techniques have been proposed to evaluate the potential for 
successful ETV outcome. Authors have suggested the Intraoperative impression can 
be classified and scored.28, 40, 69 However, reproducible, objective measurements of 
many of these features is extremely difficult and further blinded prospective trials 
have been suggested. 16 Intra-operative hydrostatic pressure testing has been shown to 
have a positive predictive value of 86.9%. 37 Yet, this technique probably provides 
little insight into late failures.  Several scoring systems have been developed that 
consider numerous criteria including; age, aetiology, previous shunt, choroids plexus 
cauterization and in some instances radiographic features. 12, 38, 41, 43, 66 While age 
appears to have a strong correlation with success (in the paediatric population in 
particular), scoring systems don’t have predictive quality that gives operators full 
confidence in future ETV success.  Cine phase-contrast MRI is widely used to assess 
the function of an ETV stoma, however there is evidence of patency of ETV in upto 
50% of failed cases.9 Faggin et al conclude that cine phase-contrast MRI has high 
capacity to detect flow, and subsequently raise suspicion of ETV failure.19 Literature 
review reveals that radioisotope cisternography, 20, 21, 34, 48intraoperative ventriculo-
stomography,32 outflow resistance,61and transcranial doppler sonography463 have been 
investigated to some degree to predict ETV success, none of which are widely used 
 
techniques. Numerous authors have suggested that measuring ICP post-ETV would 
provide accurate assessment of stoma function and ‘opening up’ of the SAS and 
evaluation of the ‘adaptation period’. 1, 23, 27, 31  
We investigated 63 patients who underwent an ETV followed by insertion of EVD 
and post-operative ICP monitoring. The mean weighted duration of monitoring was 
68.6 hours. We assessed a successful ETV outcome as resolution from symptoms of 
hydrocepalus and shunt independence. Santamarta concluded that delayed failure of 
ETV is rare and that there is a 90% cumulative probability that failure will declare 
itself during the first 16 days post surgery.54 Given this understanding, the primary 
purpose of our study was to determine if ICP monitoring and subsequent response to 
the data provided by the monitoring had a predictive quality on the early successful 
outcome of the ETV. The literature is not clear on the predictive quality of ICP 
monitoring, nor on the value of ICP patterns post-ETV. Rapana had concluded that 
“no relationship could be established between the post-operative course and late 
outcome.”50 While Cinalli et al suggest that there is some predictive quality between 
certain ICP trend patterns. 10 Our results indicate that ICP monitoring has a Positive 
Predictive Value (PPV) of 76.3% with a 95% confidence interval 58.9% - 88.6%. The 
receiver operator curve area was calculated at 0.786. All patients that failed 
monitoring (i.e., sustained high ICPs and/or clinical signs to suggest intracranial 
hypertension) went on to have VPS. Hence, the negative predictive quality for this 
test was 100%. 
 
Greenfield et al. in a prospective study concluded that an intraoperative assessment is 
more reliable than post-operative MRI and EVD pressure monitoring.28 Our findings 
with respect to the surgeon’s intraoperative impression revealed a PPV of 76.5% with 
 
a 95% confidence interval of 58.8% - 89.3%, almost identical to that of ICP 
monitoring. The Negative Predicitive Value (NPV) for the intraoperative impression 
was 76.9%.  
 
To our knowledge there is no study that has evaluated the CSF attained at ETV and 
compared to outcome. Not surprisingly, the predictive quality of CSF analysis was 
poor, (PPV 63.6%, NPV 38.2%, AUROC 0.51) with wide confidence intervals. In a 
recent study published by Ozisik, recommendation is made for placement of lumbar 
drain to encourage flow across the stoma, in selected patients. 49  Our data indicated 
that there was no predictive quality to CSF release, irrespective of method (via LP or 
EVD), nor was there an increased risk of developing sepsis. However, although not 
statistically significant, when compared to EVD CSF release, LP are associated with a 
higher likelihood of success. 
 
Methodological Limitations of the Study 
Owing to its retrospective design, this study has limitations; generally the same 
consultant staff would make the decision of failure or success during the course of 
normal clinical activities. There was no design into this study to have peer review, 
thus surgeon bias is a consequence. In addition the data collected was from nursing 
chart documentation that are captured irrespective of the clinical state (or times of 
physiologically raised ICP), but researches would have been blinded to this fact. The 
single daily and maximum ICP readings could be criticized for the same reason that 
these events may well have been missed as they did not coincide with charting / 
review times. A continuous ICP capture with trend analysis could overcome this 
 
problem. However, the current limitations are not far removed from the reality on 
which clinical decisions are taken, and thus may be more relevant. 
The lost to follow up rate of the study population, as noted previously, is thought to 
be due to the type of underlying pathologies, (often terminal) and the nature of the 
population. (lower socio-economic strata and geographically dispersed sample) 
Attempts to contact patients resulted in little improvement in the follow up numbers 
achieved, perhaps a prospective study with formal data collection and return 
incentives would improve follow up numbers. 
 
Analysis methodology 
We have chosen to represent the prevalence ratio for the data based on review of 
article by Thompson et al. that suggests that the prevalence ratio is conservative, 
consistent, and interpretable relative to the intrinsic relative ratio and should be used 
in preference to the prevalence odds ratio. 60 
 
Conclusion  
There is presently no completely reliable means of predicting successful ETV 
outcome, many patients may undergo an ‘adaptation period’ while the SAS develops 
its absorptive capacity. During this time, ETV may be deemed to have failed – having 
EVD insitu, monitoring patients and removing CSF appears to have no detrimental 
effect on the rate of sepsis, provides an element of safety and reasonable predictive 
quality test. Both surgeons’ intraoperative impression and post-operative ICP 
monitoring have a role to play in predicting the future functional state of ETV, 
interestingly the two modalities offer almost identical predictive quality with respect 
to a successful procedure.   
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